Filing Details

Accession Number:
0000899243-20-017608
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-24 21:22:58
Reporting Period:
2020-06-23
Accepted Time:
2020-06-24 21:22:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1538927 Forma Therapeutics Holdings Inc. FMTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242992 P Timothy Clackson C/O Forma Therapeutics Holdings, Inc.
500 Arsenal Street, Suite 100
Watertown MA 02472
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-23 23,590 $0.00 23,590 No 4 P Direct
Enterprise 5 Junior Stock Disposition 2020-06-23 35,067 $0.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 S Direct
Footnotes
  1. Effective immediately upon the closing of the Registrant's initial public offering on June 23, 2020, the reporting person converted 35,067 shares of Enterprise 5 Junior Stock at a conversion rate of 0.6727 shares of common stock per one share of Enterprise 5 Junior Stock, resulting in his acquisition of 23,590 shares of common stock.